Cg Oncology Inc’s filing revealed that its Director Mulay James unloaded Company’s shares for reported $0.58 million on Jan 09 ’26. In the deal valued at $52.47 per share,11,145 shares were sold. As a result of this transaction, Mulay James now holds 0 shares worth roughly $0.0.
Then, JAMES MULAY bought 13,109 shares, generating $549,660 in total proceeds.
Before that, POST LEONARD E sold 1,000 shares. Cg Oncology Inc shares valued at $41,430 were divested by the Director at a price of $41.43 per share. As a result of the transaction, POST LEONARD E now holds 0 shares, worth roughly $0.0.
Wedbush initiated its Cg Oncology Inc [CGON] rating to an Outperform in a research note published on December 11, 2025; the price target was $70. A number of analysts have revised their coverage, including Truist’s analysts, who began to cover the stock in late November with a ‘”a Buy”‘ rating. Guggenheim began covering CGON with “Buy” recommendation on October 08, 2025. Piper Sandler started covering the stock on August 19, 2025. It rated CGON as “an Overweight”.
Price Performance Review of CGON
On Friday, Cg Oncology Inc [NASDAQ:CGON] saw its stock jump 3.13% to $54.73. Over the last five days, the stock has gained 0.98%. Cg Oncology Inc shares have risen nearly 84.84% since the year began. Nevertheless, the stocks have risen 31.82% over the past one year.
How much short interest is there in Cg Oncology Inc?
A steep rise in short interest was recorded in Cg Oncology Inc stocks on 2025-12-31, dropping by -0.79 million shares to a total of 12.92 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 13.71 million shares. There was a decline of -6.15%, which implies that there is a negative sentiment for the stock.
